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Removable clips for mitral valve
repair
To the Editor:
An adequate length of artificial chordae is a
major concern for surgeons performing
nonresective mitral valvulopasties. The tech-
nique described by Tam and colleagues1 is
interesting but presents the major drawback
that, should the length of the chordae prove
to be inadequate, it cannot be modified
easily.
Our department has developed a tech-
nique that allows modification of the length
of the chordae as many times as is neces-
sary by using removable clips (HEM-O-
LOK, REF:544220; Weck Laboratories,
Inc, City of Industry, Calif). These clips
were initially designed for temporary ex-
ternal occlusion of small vessels in vascu-
lar surgery.
Once the number and location have
been decided, the artificial chordae are
implanted in the heads of the correspond-
ing papillary muscle, and the two needles
of the thread are put through the free
edge of the corresponding part of the
mitral valve. The Carpentier ring is then
placed in the usual manner. Once the
length of the artificial chordae has been
determined, using the ring as a reference,
the clip is tied on the two thread ends of
the same thread to prevent the valve from
sliding on the thread when performing
the competence test.
The competence test is performed by
injecting a saline solution through the aorta
to fill the left ventricle. To create an artifi-
cial aortic insufficiency, we press the aorta
at the level of the aortic valve with the
thumb.
The artificial chordae length can be
modified by opening the clip and closing it
elsewhere on the artificial chordae. When
the competence test is satisfactory, the
threads are knotted on the clips, which can
then be removed.
However, we do not remove the clips
but rather tie knots to avoid further sliding
of the clip. We leave them in place to
Figure 1. The forceps on the left are used
to close the clip, and the ones on the right
are used to open it by closing the forceps
at the head of the clip. These clips do not
alter the polytetrafluoroethylene thread
(Gore-Tex thread; registered trademark of
W. L. Gore & Associates, Inc, Newark,
Del).
Figure 2. Operative viewwhen closing a clip.
Figure 3. Operative view with 2 clips
placed on the anterior leaflet.
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equalize the pressure over the entire sur-
face of the clip.
We have applied this technique for 2 years
now in 48 patients to correct P2 prolapse,
bileaflet prolapse, and even Barlow disease.
In the case of endocarditis, we prefer to
use resective techniques rather than the one
described here (Figure 1-3).
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Intraoperative ablation of atrial
fibrillation using bipolar output of
surgical radiofrequency generator
(diathermy) and reusable bipolar
forceps
To the Editor:
My colleagues and I began using bipolar
radiofrequency (RF) ablation in August
1996 and published the first clinical
study in the European Journal of Cardio-
thoracic Surgery.1 We used the standard
bayonet-shaped bipolar forceps with a 7-mm
tip to draw ablation lines, which replaced
most of the incisions of the Cox maze III
procedure. The larger experience with this
technique was published in Heart, Lung
and Circulation.2
A number of bipolar RF ablation de-
vices have been used experimentally and
clinically. The results of these studies have
been published in this Journal. One such
study is that by Gaynor and associates.3
They tried to do exactly what we described
in our publication in an indexed journal.
Similarly, Gillinov and coworkers4 have
used bipolar RF with different lesion sets.
In addition, our letter to Editor5 clearly
defines the advantage of bipolar RF over
unipolar RF in avoiding collateral damage.
In the abstract to the article by Benussi and
associates,6 the “Objective” section states,
“Bipolar radiofrequency proved highly ef-
fective in the animal model, but clinical
experience is still initial.”
I am at a loss to understand the reasons
for the omission, in this Internet era, of
reference to our original work published
much earlier. I am absolutely sure that this
omission was not intentional, yet I am led
to believe it is a scientific lapse.
Therefore, I believe it would be appro-
priate to bring to the notice of the readers
that intraoperative ablation of atrial fibril-
lation with bipolar RF is possible with a
good success rate without additional costs
of special RF equipment and disposable
bipolar clamps. The technique is described
in detail in reference 2. It is the purpose of
this letter to highlight the fact that the stan-
dard RF generator with bipolar output can
be used with the bayonet-shaped bipolar
forceps to effect ablation lines on the atria
and achieve a success similar to that of
modified maze procedures. Our ongoing
work, begun 10 years, ago emphasizes that
our approach is highly successful, simple,
and eminently cost-effective.
A. M. Patwardhan, MD
CVTS Department
Seth G.S.Medical College and K.E.M. Hospital
Parel, Mumbai, India
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Reply to the Editor:
Dr Patwardhan complains that two seminal
papers describing his pioneering experi-
ence in surgical ablation with bipolar co-
agulation1,2 were not given due consider-
ation in articles published by us3 and by
others.
We recognize that Patwardhan’s intui-
tions opened the way to the modern sce-
nario of surgical ablation. Nevertheless,
only 2 of 74 articles among PubMed-listed
clinical papers focusing on atrial fibrilla-
tion (AF) ablation with bipolar radiofre-
quency (RF) (by matching AF with bipolar
RF) quote Patwardhan’s works.
There are different possible reasons for
this reiterated omission:
First of all, Patwardhan and colleagues
reported using a standard electrocautery in
the bipolar mode to ablate the atrial myo-
cardium. This is not perceived by us (and
probably by most surgeons) as being in
accordance with some fundamental safety
issues: Power-based RF can lead to char-
ring and to excessive endocardial trauma,
potentially leading to an increased risk of
thromboembolism. Furthermore, also due
to the absence of any feedback controlling
energy delivery, electrocoagulation can
cause excessive tissue weakening, possibly
leading to bleeding. Re-exploration for
bleeding occurred in 20% of survivors in
Patwardhan’s initial series.1 Temperature
and impedance feedback, featured by com-
mercially available bipolar devices, are ac-
tually meant to address such problems.
It is then not irrelevant that bipolar elec-
trocautery, despite sharing the same phys-
ical principles of commercially available
RF ablation devices, is not CE- or Food
and Drug Administration–marked for
cardiac ablation. As a result, most sur-
geons, including our group, would rather
avoid the “off-label” use of a bipolar
electrocautery and indulge in the use of
more recognized commercially available
alternatives.
Furthermore, Patwardhan’s spot-by-
spot ablation without tissue feedback can
admittedly lead to the creation of incom-
plete ablation lines, rendering the ablation
procedure not reproducible and clinical re-
sult possibly suboptimal.
It is finally worth mentioning that Path-
wardhan’s electrocautery ablation is an
open-heart procedure. Electrocautery for-
ceps, in fact, despite being bipolar, do not
share the epicardial clamping feature that
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